Related Experiment Video
Updated: May 30, 2025

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
Published on: April 6, 2017
Inhalable Nano Formulation of Cabazitaxel: A Comparative Study with Intravenous Route
Elif Kaga1, Sadik Kaga2, Korhan Altunbas3
1Department of Medical Services and Techniques, Afyonkarahisar Health Sciences University, Afyonkarahisar, 03030, Türkiye.
This study compared free and nanoparticle Cabazitaxel (CBZ) lung cancer treatments. Nanoparticle formulations administered via inhalation showed reduced toxicity and improved retention compared to intravenous routes.
Area of Science:
- Pharmacology
- Nanotechnology
- Oncology
Background:
- Intravenous (IV) chemotherapy is standard for lung cancer, but pulmonary (inhaled) administration offers an alternative.
- Cabazitaxel (CBZ) is a chemotherapy drug used for lung cancer.
Purpose of the Study:
- To investigate the biochemical and histological effects of free and nanoparticle CBZ formulations after IV and inhaled (INH) administration in rats.
- To evaluate the efficacy and toxicity of a novel PEGylated polystyrene nanoparticle (NP) formulation of CBZ.
Main Methods:
- Rats received free CBZ or CBZ NP formulations via IV or INH routes.
- Biochemical and histological parameters were assessed.
- Blood samples were collected at 24 and 48 hours post-administration.
- Nanoformulations were prepared using PEGylated polystyrene nanoparticles via PISA.
Main Results:
- Free CBZ formulations (IV or INH) exhibited higher systemic toxicity.
- CBZ NP formulations showed no toxicity via either IV or INH routes.
- Inhaled CBZ NP formulations demonstrated enhanced and prolonged drug retention in the lungs.
- Histological analysis revealed increased alveolar macrophage migration with inhaled CBZ NP due to enhanced retention.
Conclusions:
- Nanotechnology combined with the pulmonary route offers an advantage for developing inhalable nanomedicines for lung cancer.
- The inhaled nanoparticle formulation of CBZ presents a potentially safer and more effective treatment strategy for lung cancer.
Related Concept Videos
Additional Routes of Drug Administration
Administering drugs via inhalation allows for the direct delivery of gaseous, volatile substances or droplets to different parts of the respiratory tract. One of the advantages of the inhalation route is the rapid absorption of drugs into the circulatory system, which is possible because of the large surface area of...
Drug Delivery: Miscellaneous Routes
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Routes of Drug Administration: Parenteral
The intravenous route (IV) of drug administration can be further categorized into two types. The bolus injection administers the entire dose rapidly, while an intravenous infusion slowly delivers smaller doses steadily.
The IV route is often...
Drug Delivery: Overview
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Non-Oral Extravascular Drug Absorption Routes
Lipophilic drugs that are stable at salivary pH (6) and exhibit minimal binding to the oral mucosa are absorbed more...
Drug Delivery: Parenteral Route
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...

